Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00711347 · ClinicalTrials.gov registry record · Phase 4
Intraoperative Floppy Iris Syndrome
A Phase 4 study, sponsored by Alcon Research.
- Completed
- Registry status
- Phase 4
- Development phase
- 28
- Enrollment target
NCT00711347 is a Phase 4 study that has completed, run by Alcon Research. The registered enrollment target is 28 participants.
The verdict
NCT00711347, a Phase 4 study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 28 participants
- Enrollment target
Study Summary
An assessment of the surgical performance of DisCoVisc compared to Healon5 during cataract surgery with intraocular lens implantation where miotic/small pupils or intraoperative Floppy Iris Syndrome exists.
Interventions
- DEVICE DisCoVisc
- DEVICE Healon5
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2007-06 |
| Est. Completion | 2008-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00711347
The ClinicalTrials.gov registry entry for NCT00711347 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which DisCoVisc is the first listed.
NCT00711347 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00711347 about?
NCT00711347 is a clinical study titled "Intraoperative Floppy Iris Syndrome". An assessment of the surgical performance of DisCoVisc compared to Healon5 during cataract surgery with intraocular lens implantation where miotic/small pupils or intraoperative Floppy Iris Syndrome exists.
What is the current status of trial NCT00711347?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 28 participants. The study started on 2007-06. Estimated completion is 2008-04.
What interventions are being tested in trial NCT00711347?
The interventions under investigation include: DisCoVisc (DEVICE), Healon5 (DEVICE).
Who is sponsoring clinical trial NCT00711347?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.